Tung-Liang Lin
Overview
Explore the profile of Tung-Liang Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chen N, Chang H, Kuo M, Lin T, Shih L, Chuang W, et al.
J Formos Med Assoc
. 2023 Aug;
123(2):188-197.
PMID: 37558588
Purpose: We aimed to explore the clinical outcomes and prognostic factors for PTCL-NOS patients in the real world. Methods: Clinical data were retrospectively collected from adult patients with PTCL-NOS treated...
12.
Chen N, Chang H, Kao H, Ou C, Kuo M, Wang P, et al.
Clin Exp Med
. 2023 Apr;
23(7):3759-3766.
PMID: 37086332
Prognosis of diffuse large B cell lymphoma (DLBCL) can be predicted by various factors. The most widely used tool for prediction is the international prognostic index (IPI). β2-microglobulin is a...
13.
Fu W, Bang S, Huang H, Kim K, Li W, An G, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Apr;
23(6):446-455.e4.
PMID: 37024420
Introduction: In the global phase 3 ALCYONE trial, daratumumab plus bortezomib/melphalan/prednisone (D-VMP) improved outcomes versus VMP in transplant-ineligible newly diagnosed multiple myeloma (NDMM) patients. Here, we report the primary analysis...
14.
Kuo M, Chuang W, Chang H, Lin T, Wu J, Lin T, et al.
Am J Clin Pathol
. 2023 Mar;
159(5):474-483.
PMID: 36857745
Objectives: The clinical presentations of essential thrombocythemia (ET) may be quite similar to early/prefibrotic primary myelofibrosis (pre-PMF), especially in pre-PMF presenting with thrombocytosis (pre-PMF-T), but may be associated with a...
15.
Liu H, Kuo M, Wu K, Chen T, Chen J, Wang M, et al.
Br J Cancer
. 2023 Jan;
128(7):1294-1300.
PMID: 36717672
Background: The direct comparison of molecular responses of front-line imatinib (IM) monitored at the same laboratory between children and adults with chronic phase (CP) of chronic myeloid leukaemia (CML) had...
16.
Kao H, Kuo M, Huang Y, Chang H, Hu S, Huang C, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551690
Locked nucleic acid quantitative Real-Time PCR (LNA-qPCR) for IDH1/2 mutations in AML measurable residual disease (MRD) detection is rarely reported. LNA-qPCR was applied to quantify IDH1/2 mutants MRD kinetics in...
17.
Su Y, Kuo M, Chen T, Wang M, Yang Y, Ma M, et al.
Cancer Sci
. 2022 Jul;
113(10):3518-3527.
PMID: 35869805
Several studies have compared the molecular responses between e14a2 and e13a2 BCR::ABL1 transcripts in chronic myeloid leukemia (CML) patients treated with front-line imatinib, but there were very limited studies on...
18.
Sunami K, Ikeda T, Huang S, Wang M, Koh Y, Min C, et al.
Clin Lymphoma Myeloma Leuk
. 2022 May;
22(8):e751-e761.
PMID: 35641409
Background: In the pivotal phase III, randomized, multicenter ICARIA-MM study (NCT02990338), isatuximab plus pomalidomide and dexamethasone (Isa-Pd) improved progression-free survival and overall response rate versus pomalidomide and dexamethasone (Pd) in...
19.
Wang Y, Hsieh C, Hsiao L, Lin T, Liu Y, Yao M, et al.
Sci Rep
. 2022 Apr;
12(1):5662.
PMID: 35383213
Mantle cell lymphoma (MCL) is a B-cell lymphoma featuring an aggressive course and a progressive relapsing pattern. International guidelines recommend early consolidative autologous stem cell transplant (auto-SCT) for eligible patients...
20.
Chang H, Kuo M, Tang T, Lin T, Wu J
Biomed J
. 2022 Mar;
44(6 Suppl 2):S252-S257.
PMID: 35292266
Background: Patients with acute myeloid leukemia (AML) are at risk of hepatosplenic candidiasis (HSC). HSC is often associated with prolonged fever and difficulty in definitive clinical diagnosis. We aimed to...